Etizolam 1mg Tablet Franchise in Ahmedabad

Anti-Anxiety & Sedative Tablet Supplier in Bangalore

Etizolam Tablet Distributor in Hyderabad

Stress & Sleep Disorder Tablet Franchise Opportunity in Jaipur

Psychiatric Medicine Tablet Stockist in Mumbai
Etizolam Tablet Export & Manufacturing in Chandigarh

Home/Products /etizolam-1mg-tablet

Etilome 1 Tablet

Composition : Etizolam (1mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Etilome 1 Tablet contains Etizolam 1mg, a thienodiazepine with anxiolytic, sedative, and muscle-relaxant properties. It is commonly used for the treatment of generalized anxiety disorder, acute stress episodes, and short-term insomnia, promoting relaxation and better sleep quality.

The 1mg dosage provides effective symptom control while minimizing sedation and dependency risk, making it suitable for both initial therapy and maintenance under medical supervision.

For hospitals, psychiatric clinics, and distributors, Etilome 1 Tablet is a high-demand anti-anxiety product, regularly stocked in outpatient mental health departments, sleep clinics, and psychiatric care units. Its consistent use ensures regular orders and steady market presence.

Adding Etilome 1 Tablet to your portfolio strengthens your mental health and psychiatric segment, providing opportunities in hospital supply, pharmacy distribution, institutional orders, export channels, and third-party manufacturing. Its proven efficacy and wide clinical use make it a valuable and profitable addition for pharmaceutical distributors.

Read More

About the Product

Etilome 1 Tablet contains Etizolam 1mg, a thienodiazepine with anxiolytic, sedative, and muscle-relaxant properties. It is commonly used for the treatment of generalized anxiety disorder, acute stress episodes, and short-term insomnia, promoting relaxation and better sleep quality.

The 1mg dosage provides effective symptom control while minimizing sedation and dependency risk, making it suitable for both initial therapy and maintenance under medical supervision.

For hospitals, psychiatric clinics, and distributors, Etilome 1 Tablet is a high-demand anti-anxiety product, regularly stocked in outpatient mental health departments, sleep clinics, and psychiatric care units. Its consistent use ensures regular orders and steady market presence.

Adding Etilome 1 Tablet to your portfolio strengthens your mental health and psychiatric segment, providing opportunities in hospital supply, pharmacy distribution, institutional orders, export channels, and third-party manufacturing. Its proven efficacy and wide clinical use make it a valuable and profitable addition for pharmaceutical distributors.

Some patients may experience drowsiness, dizziness, fatigue, headache, or mild gastrointestinal discomfort. Rarely, memory impairment, hypotension, or allergic reactions may occur.

Etilome 1 Tablet is indicated for the treatment of anxiety disorders, panic attacks, and insomnia associated with anxiety. It helps alleviate tension, nervousness, and promotes relaxation and better sleep patterns.

Use strictly under medical supervision. Avoid driving or operating machinery while on this medication. Do not discontinue abruptly without consulting a doctor, as withdrawal symptoms may occur. Avoid in patients with hypersensitivity to Etizolam or history of substance abuse.

Store in a cool, dry place below 25°C, away from light and moisture. Keep out of reach of children.

Get in Touch

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.

Quick Navigation

1500+ Products

Our Divisions

All Therapeutics

Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.